Edgar Lomax Company’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.6M | Sell |
133,545
-38,450
| -22% | -$8.96M | 2.33% | 16 |
|
|
2025
Q4 | $35.6M | Sell |
171,995
-166,125
| -49% | -$32.9M | 2.7% | 12 |
|
|
2025
Q3 | $62.7M | Sell |
338,120
-101,005
| -23% | -$17.3M | 4.91% | 2 |
|
|
2025
Q2 | $67.1M | Sell |
439,125
-7,170
| -2% | -$1.1M | 4.24% | 6 |
|
|
2025
Q1 | $74M | Buy |
446,295
+66,955
| +18% | +$10.5M | 4.63% | 3 |
|
|
2024
Q4 | $54.9M | Buy |
379,340
+174,700
| +85% | +$27.1M | 3.54% | 7 |
|
|
2024
Q3 | $33.2M | Sell |
204,640
-3,200
| -2% | -$510K | 2.02% | 19 |
|
|
2024
Q2 | $30.4M | Sell |
207,840
-2,635
| -1% | -$392K | 1.97% | 20 |
|
|
2024
Q1 | $33.3M | Buy |
210,475
+112,608
| +115% | +$17.9M | 2.06% | 19 |
|
|
2023
Q4 | $15.3M | Sell |
97,867
-4,420
| -4% | -$678K | 1% | 34 |
|
|
2023
Q3 | $15.9M | Sell |
102,287
-1,865
| -2% | -$308K | 1.08% | 31 |
|
|
2023
Q2 | $17.2M | Sell |
104,152
-1,418
| -1% | -$229K | 1.14% | 32 |
|
|
2023
Q1 | $16.4M | Sell |
105,570
-63,005
| -37% | -$10.2M | 1.05% | 32 |
|
|
2022
Q4 | $29.8M | Sell |
168,575
-950
| -0.6% | -$164K | 1.81% | 22 |
|
|
2022
Q3 | $27.7M | Sell |
169,525
-950
| -0.6% | -$161K | 1.91% | 20 |
|
|
2022
Q2 | $30.3M | Buy |
170,475
+4,725
| +3% | +$842K | 1.9% | 20 |
|
|
2022
Q1 | $29.4M | Sell |
165,750
-55,850
| -25% | -$9.5M | 1.72% | 22 |
|
|
2021
Q4 | $37.9M | Sell |
221,600
-2,020
| -0.9% | -$331K | 2.27% | 16 |
|
|
2021
Q3 | $36.1M | Sell |
223,620
-2,205
| -1% | -$376K | 2.32% | 15 |
|
|
2021
Q2 | $37.2M | Sell |
225,825
-6,025
| -3% | -$997K | 2.31% | 18 |
|
|
2021
Q1 | $38.1M | Buy |
+231,850
| New | +$37.5M | 2.38% | 16 |
|
|
2019
Q1 | – | Sell |
-131,879
| Closed | -$17M | – | 71 |
|
|
2018
Q4 | $17M | Sell |
131,879
-2,400
| -2% | -$335K | 1.29% | 25 |
|
|
2018
Q3 | $18.6M | Sell |
134,279
-4,900
| -4% | -$651K | 1.25% | 28 |
|
|
2018
Q2 | $16.9M | Buy |
139,179
+935
| +0.7% | +$117K | 1.19% | 28 |
|
|
2018
Q1 | $17.7M | Buy |
138,244
+30,500
| +28% | +$4.12M | 1.27% | 28 |
|
|
2017
Q4 | $15.1M | Sell |
107,744
-3,200
| -3% | -$446K | 1.03% | 34 |
|
|
2017
Q3 | $14.4M | Sell |
110,944
-9,901
| -8% | -$1.31M | 1.02% | 34 |
|
|
2017
Q2 | $16M | Sell |
120,845
-3,200
| -3% | -$408K | 1.09% | 34 |
|
|
2017
Q1 | $15.4M | Buy |
124,045
+119,135
| +2,426% | +$14.2M | 1.03% | 35 |
|
|
2016
Q4 | $566K | Buy |
+4,910
| New | +$567K | 0.04% | 59 |
|
|
2016
Q1 | – | Sell |
-265,910
| Closed | -$27.3M | – | 66 |
|
|
2015
Q4 | $27.3M | Sell |
265,910
-276,500
| -51% | -$27.8M | 2% | 19 |
|
|
2015
Q3 | $50.6M | Sell |
542,410
-19,450
| -3% | -$1.88M | 3.84% | 8 |
|
|
2015
Q2 | $54.8M | Sell |
561,860
-7,150
| -1% | -$716K | 3.67% | 8 |
|
|
2015
Q1 | $57.2M | Buy |
569,010
+518,750
| +1,032% | +$52.8M | 3.74% | 8 |
|
|
2014
Q4 | $5.26M | Sell |
50,260
-25,706
| -34% | -$2.71M | 0.33% | 51 |
|
|
2014
Q3 | $8.1M | Buy |
75,966
+1,910
| +3% | +$198K | 0.55% | 37 |
|
|
2014
Q2 | $7.75M | Buy |
74,056
+150
| +0.2% | +$15.2K | 0.55% | 37 |
|
|
2014
Q1 | $7.26M | Sell |
73,906
-146,250
| -66% | -$13.6M | 0.54% | 40 |
|
|
2013
Q4 | $20.2M | Sell |
220,156
-84,300
| -28% | -$7.77M | 1.52% | 28 |
|
|
2013
Q3 | $26.4M | Sell |
304,456
-28,500
| -9% | -$2.56M | 2.16% | 16 |
|
|
2013
Q2 | $28.6M | Buy |
+332,956
| New | +$28.3M | 2.22% | 16 |
|
Other funds holding JNJ
VCM
VPM
Edgar Lomax Company's JNJ Position: Q1 2026 in Review
Edgar Lomax Company reduced its Johnson & Johnson (JNJ) stake by 22% in Q1 2026, selling an estimated $8.96M and leaving 133,545 shares worth $32.6M. The position accounts for 2.33% of the portfolio, ranked #16.
Edgar Lomax Company first reported a position in JNJ in Q2 2013 and has held it in 41 quarters since. The position peaked at $74M in Q1 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Edgar Lomax Company held 133,545 shares of Johnson & Johnson worth $32.6M as of Q1 2026.
- Edgar Lomax Company sold 38,450 Johnson & Johnson shares in Q1 2026, an estimated $8.96M.
- Johnson & Johnson made up 2.33% of Edgar Lomax Company's portfolio in Q1 2026, its #16 holding.
- Edgar Lomax Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 41 quarters since.
- Edgar Lomax Company's Johnson & Johnson position peaked at $74M in Q1 2025.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Edgar Lomax Company's 13F filing for Q1 2026, filed 12 May 2026.